Publications To Date


    Filter Publications

    PAGE 65 OF 75 | DISPLAYING 961 - 975 OF 1112 RESULTS

    Northcott P. et al., Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma., [Epub ahead of print]., Nature, Jun 22, 2014

    Ichida J.K. et al., Notch inhibition allows oncogene-independent generation of iPS cells., [Epub ahead of print]., Nature Chem. Biol., Jun 22, 2014

    Li J. et al., 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy., [Epub ahead of print]., Nature Commun., Jun 17, 2014

    Chakravadhanula M. et al., Expression of Hox Genes and Hotair in Atrt and Other Pediatric Brain Tumors., [Epub ahead of print]., Cancer Genetics, Jun 10, 2014

    Jin Y. et al., MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2., [Epub ahead of print]., Oncotarget, May 30, 2014

    Guancial C.M. et al., FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder., [Epub ahead of print]., Cancer Medicine, May 20, 2014

    Martin J.W. et al., Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma., [Epub ahead of print]., PLoS ONE, May 16, 2014

    Perreault S. et al., MRI surrogates for molecular subgroups of Medulloblastoma., [Epub ahead of print]., AJNR AM J Neuroradiol., May 15, 2014

    Mairinger F.D. et al., Activation of Angiogenesis Differs Strongly Between Pulmonary Carcinoids and Neuroendocrine Carinomas and Is Crucial for Carcinoid Tumourgenesis., [Epub ahead of print]., J. Cancer, May 15, 2014

    Welch J.S. et al., A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML., [Epub ahead of print]., Am. J. Haematol., Apr 28, 2014

    Dekervel J. et al., Hypoxia-Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer Patients., [Epub ahead of print]., Clin. Cancer Res., Apr 15, 2014

    Valeri N. et al., MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer., [Epub ahead of print]., Cancer Cell, Apr 14, 2014

    Momen-Heravi F. et al., Genomewide study of salivary MicroRNAs for detection of oral cancer , [Epub ahead of print]., J Den res., Apr 09, 2014

    Huang W.T. et al., EBV-encoded miR-BART20-5p and miR-BART8 Inhibit the IFN-γ–STAT1 pathway associated with disease progression in nasal NK-cell lymphoma., 184 (4):1185–1197, J. Pathology, Apr 01, 2014

    Morfouace M. et al., Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 Medulloblastoma., [Epub ahead of print]., Cancer Cell, Mar 27, 2014